|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02407 GAUSH MEDITECH
Nominal 
5.790 -0.530 (-8.386%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | -- | -- | 1,428,397 | 1,406,238 | 1,253,785 | 1,298,218 |
| Cost of Sales | -- | -- | (765,008) | (714,638) | (628,447) | (688,747) |
| Gross Profit | -- | -- | 663,389 | 691,600 | 625,338 | 609,471 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (307,426) | (375,606) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | -- | -- | 155,287 | 247,735 | (275,094) | (137,964) | |
| Taxation | -- | -- | (66,764) | (74,821) | (77,618) | (53,607) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 3,871 | 609 | 3,093 | 1,124 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 96,189 | 4.107% | 92,394 | 173,523 | (349,619) | (190,447) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | 33,534 | 44,027 | 38,007 | 81,505 |
| Depreciation & Amortisation | -- | -- | 81,943 | 75,967 | 65,748 | 60,060 |
| Directors' Emoluments | -- | -- | 5,548 | 5,814 | 4,646 | 4,463 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 66.000 | 4.762% | 63.000 | 117.000 | -361.000 | -199.000 |
| DPS (cts) | 0.000 | -- | 27.688 | 99.773 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | 43.950% | 85.276% | -- | -- |
| Cash flow per share ($) | -- | -- | 0.729 | 1.683 | 2.418 | 1.716 |
| NBV per share ($) | -- | -- | 10.651 | 11.357 | 9.934 | -- |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 96,189 |
| %Change | 4.107% |
| EPS / (LPS) | RMB 0.660 |
| NBV Per Share (¥) | RMB -- |